Having qualified as a Pharmacist in 2013 and having an interest in pharmaceutical formulation development and oncology, I began a PhD focusing on the development of a novel skin cancer treatment. An ever increasing search in in progress for novel active pharmaceutical ingredients. However we must go beyond the simple identification of useful active's that provide the basis for novel claims and benefits. As formulation scientists we must determine the active compounds absoption, body distribution, metabolism and excretion thus formulate a suitable delivery system. I aim to reduce side effects via effective targetting, and, in view of the high cost that can accompany new materials, incorportate these compounds into targerted, controlled-release delivery systems.

My research focuses on advanced drug delivery and translational therapeutics, particularly for chronic conditions such as drug-resistant epilepsy and diabetic complications. I have expertise in transdermal formulations, including microneedles, liposomes, polymeric carriers, and hydrogels, designed to enhance targeted and controlled drug release. I integrate interdisciplinary approaches—combining pharmacology, biomaterials, and bioengineering—to overcome physiological barriers and improve therapeutic efficacy. My work spans preclinical modelling, patient-informed formulation design, and assessment of bioactivity in vitro and in vivo. Ultimately, I aim to translate innovative delivery systems into clinically relevant solutions that improve patient outcomes and foster international research collaboration.

• Telephone: 0121 204 5052
• Email: [email protected]
  
• Room Number: MB 319